Beth C Seidenberg - Net Worth and Insider Trading
Beth C Seidenberg Net Worth
The estimated net worth of Beth C Seidenberg is at least $634 Million dollars as of 2024-05-01. Beth C Seidenberg is the Director of Progyny Inc and owns about 8,984,120 shares of Progyny Inc (PGNY) stock worth over $288 Million. Beth C Seidenberg is the Director of Tesaro Inc and owns about 2,934,321 shares of Tesaro Inc (TSRO) stock worth over $220 Million. Beth C Seidenberg is also the Director of Vera Therapeutics Inc and owns about 1,949,295 shares of Vera Therapeutics Inc (VERA) stock worth over $77 Million. Besides these, Beth C Seidenberg also holds Acelyrin Inc (SLRN) , Sagimet Biosciences Inc (SGMT) , Atara Biotherapeutics Inc (ATRA) , BioCryst Pharmaceuticals Inc (BCRX) . Details can be seen in Beth C Seidenberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Beth C Seidenberg has not made any transactions after 2023-07-18 and currently still holds the listed stock(s).
Transaction Summary of Beth C Seidenberg
Beth C Seidenberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Beth C Seidenberg owns 10 companies in total, including Progyny Inc (PGNY) , Atara Biotherapeutics Inc (ATRA) , and Epizyme Inc (EPZM) among others .
Click here to see the complete history of Beth C Seidenberg’s form 4 insider trades.
Insider Ownership Summary of Beth C Seidenberg
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PGNY | Progyny Inc | 2021-11-17 | director |
ATRA | Atara Biotherapeutics Inc | 2021-06-08 | director |
EPZM | Epizyme Inc | 2019-03-31 | director |
TSRO | Tesaro Inc | 2019-01-22 | director |
ARMO | ARMO BioSciences Inc | 2018-06-22 | director |
BCRX | BioCryst Pharmaceuticals Inc | 2006-05-03 | director |
AMGN | Amgen Inc | 2003-07-01 | Sr VP Development |
VERA | Vera Therapeutics Inc | 2023-03-30 | director |
SLRN | Acelyrin Inc | 2023-05-09 | director & 10 percent owner |
SGMT | Sagimet Biosciences Inc | 2023-07-18 | director |
Beth C Seidenberg Latest Holdings Summary
Beth C Seidenberg currently owns a total of 7 stocks. Among these stocks, Beth C Seidenberg owns 8,984,120 shares of Progyny Inc (PGNY) as of April 15, 2021, with a value of $288 Million and a weighting of 45.42%. Beth C Seidenberg owns 2,934,321 shares of Tesaro Inc (TSRO) as of March 18, 2016, with a value of $220 Million and a weighting of 34.69%. Beth C Seidenberg also owns 1,949,295 shares of Vera Therapeutics Inc (VERA) as of March 30, 2023, with a value of $77 Million and a weighting of 12.15%. The other 4 stocks Acelyrin Inc (SLRN) , Sagimet Biosciences Inc (SGMT) , Atara Biotherapeutics Inc (ATRA) , BioCryst Pharmaceuticals Inc (BCRX) have a combined weighting of 7.75% among all his current holdings.
Latest Holdings of Beth C Seidenberg
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PGNY | Progyny Inc | 2021-04-15 | 8,984,120 | 32.06 | 288,030,887 |
TSRO | Tesaro Inc | 2016-03-18 | 2,934,321 | 74.96 | 219,956,702 |
VERA | Vera Therapeutics Inc | 2023-03-30 | 1,949,295 | 39.51 | 77,016,645 |
SLRN | Acelyrin Inc | 2023-05-09 | 9,850,729 | 4.18 | 41,176,047 |
SGMT | Sagimet Biosciences Inc | 2023-07-18 | 2,031,118 | 3.90 | 7,921,360 |
ATRA | Atara Biotherapeutics Inc | 2014-10-15 | 22,307 | 0.69 | 15,392 |
BCRX | BioCryst Pharmaceuticals Inc | 2006-05-03 | 3,000 | 4.13 | 12,390 |
Holding Weightings of Beth C Seidenberg
Beth C Seidenberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Beth C Seidenberg has made a total of 5 transactions in Progyny Inc (PGNY) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Progyny Inc is the sale of 18,127 shares on April 15, 2021, which brought Beth C Seidenberg around $912,151.
According to the SEC Form 4 filings, Beth C Seidenberg has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the acquisition of 1,420,858 shares on March 18, 2016, which cost Beth C Seidenberg around $50 Million.
According to the SEC Form 4 filings, Beth C Seidenberg has made a total of 9 transactions in Vera Therapeutics Inc (VERA) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Vera Therapeutics Inc is the acquisition of 2,300 shares on March 30, 2023, which cost Beth C Seidenberg around $16,652.
More details on Beth C Seidenberg's insider transactions can be found in the Insider Trading History of Beth C Seidenberg table.Insider Trading History of Beth C Seidenberg
- 1
Beth C Seidenberg Trading Performance
GuruFocus tracks the stock performance after each of Beth C Seidenberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Beth C Seidenberg is 36.09%. GuruFocus also compares Beth C Seidenberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Beth C Seidenberg within 3 months outperforms 11 times out of 15 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Beth C Seidenberg's insider trading performs compared to the benchmark.
Performance of Beth C Seidenberg
Average Return
338.3%
Outperforming Transactions
86%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | -2.21 | 36.09 | 79.44 | 338.3 | 28.56 | 20.53 |
Relative Return to S&P 500(%) | -2.78 | 31.62 | 72.51 | 315.04 | 12.76 | 16.86 |
Beth C Seidenberg Ownership Network
Ownership Network List of Beth C Seidenberg
Ownership Network Relation of Beth C Seidenberg
Beth C Seidenberg Owned Company Details
What does Progyny Inc do?
Who are the key executives at Progyny Inc?
Beth C Seidenberg is the director of Progyny Inc. Other key executives at Progyny Inc include President Michael E Sturmer , Chief Financial Officer Mark S. Livingston , and director & Executive Chairman David J Schlanger .
Progyny Inc (PGNY) Insider Trades Summary
Over the past 18 months, Beth C Seidenberg made no insider transaction in Progyny Inc (PGNY). Other recent insider transactions involving Progyny Inc (PGNY) include a net sale of 1,686,000 shares made by David J Schlanger , a net sale of 904,259 shares made by Peter Anevski , and a net sale of 91,679 shares made by Mark S. Livingston .
In summary, during the past 3 months, insiders sold 193,430 shares of Progyny Inc (PGNY) in total and bought 0 shares, with a net sale of 193,430 shares. During the past 18 months, 6,424,945 shares of Progyny Inc (PGNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,424,945 shares.
Progyny Inc (PGNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Progyny Inc Insider Transactions
Beth C Seidenberg Mailing Address
Above is the net worth, insider trading, and ownership report for Beth C Seidenberg. Currently GuruFocus does not have mailing address information for Beth C Seidenberg.